BioCardia BCDA Stock
BioCardia Price Chart
BioCardia BCDA Financial and Trading Overview
| BioCardia stock price | 2.01 USD |
| Previous Close | 2.24 USD |
| Open | 2.17 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1200 |
| Day's Range | 2.15 - 2.29 USD |
| 52 Week Range | 1.28 - 2.6 USD |
| Volume | 19.38K USD |
| Avg. Volume | 28.99K USD |
| Market Cap | 46.3M USD |
| Beta (5Y Monthly) | 1.019718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.9 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.5 USD |
BCDA Valuation Measures
| Enterprise Value | 43M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.4696968 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 34.145824 |
| Price/Book (mrq) | 24.361702 |
| Enterprise Value/Revenue | 31.711 |
| Enterprise Value/EBITDA | -3.585 |
Trading Information
BioCardia Stock Price History
| Beta (5Y Monthly) | 1.019718 |
| 52-Week Change | 61.26% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.6 USD |
| 52 Week Low | 1.28 USD |
| 50-Day Moving Average | 1.95 USD |
| 200-Day Moving Average | 2.01 USD |
BCDA Share Statistics
| Avg. Volume (3 month) | 28.99K USD |
| Avg. Daily Volume (10-Days) | 21K USD |
| Shares Outstanding | 20.22M |
| Float | 10.55M |
| Short Ratio | 4.1 |
| % Held by Insiders | 29.44% |
| % Held by Institutions | 15.95% |
| Shares Short | 200.57K |
| Short % of Float | 1.35% |
| Short % of Shares Outstanding | 0.99% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -891.14% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -75.64% |
| Return on Equity (ttm) | -260.71% |
Income Statement
| Revenue (ttm) | 1.36M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 6.70% |
| Gross Profit (ttm) | -7482000 USD |
| EBITDA | -11996000 USD |
| Net Income Avi to Common (ttm) | -12083000 USD |
| Diluted EPS (ttm) | -0.64 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.86M USD |
| Total Cash Per Share (mrq) | 0.24 USD |
| Total Debt (mrq) | 1.56M USD |
| Total Debt/Equity (mrq) | 81.84 USD |
| Current Ratio (mrq) | 1.322 |
| Book Value Per Share (mrq) | 0.094 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10208000 USD |
| Levered Free Cash Flow (ttm) | -6033500 USD |
Profile of BioCardia
| Country | United States |
| State | CA |
| City | Sunnyvale |
| Address | 320 Soquel Way |
| ZIP | 94085 |
| Phone | 650 226 0120 |
| Website | https://www.biocardia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Q&A For BioCardia Stock
What is a current BCDA stock price?
BioCardia BCDA stock price today per share is 2.01 USD.
How to purchase BioCardia stock?
You can buy BCDA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioCardia?
The stock symbol or ticker of BioCardia is BCDA.
Which industry does the BioCardia company belong to?
The BioCardia industry is Biotechnology.
How many shares does BioCardia have in circulation?
The max supply of BioCardia shares is 4.58M.
What is BioCardia Price to Earnings Ratio (PE Ratio)?
BioCardia PE Ratio is now.
What was BioCardia earnings per share over the trailing 12 months (TTM)?
BioCardia EPS is -2.9 USD over the trailing 12 months.
Which sector does the BioCardia company belong to?
The BioCardia sector is Healthcare.
BioCardia BCDA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 92.16 USD — |
-4.45
|
— — | 89.57 USD — | 93.85 USD — | — - | — — |
- {{ link.label }} {{link}}